AMBER JACKSON: Open Payments
NPI 1588360473 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,363 in 135 payments from 17 companies in 2025. Trend: 2023 $1,739 · 2024 $2,095 · 2025 $3,363
Food & beverage: $3,353Education: $10
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 14 | $526 |
| ABBVIE INC. | 28 | $448 |
| Galderma Laboratories, L.P. | 16 | $396 |
| Regeneron Healthcare Solutions, Inc. | 13 | $392 |
| Novartis Pharmaceuticals Corporation | 9 | $302 |
| Organon LLC | 9 | $240 |
| UCB, Inc. | 7 | $176 |
| Incyte Corporation | 4 | $152 |
| Lilly USA, LLC | 3 | $150 |
| Janssen Biotech, Inc. | 10 | $146 |
Products named: DUPIXENT, NEMLUVIO, ANZUPGO, SKYRIZI, RINVOQ, COSENTYX, Bimzelx, ADBRY.
Industry payments across AL — which companies pay providers there.
